Elliott Sigal
Board Member
Vir Biotechnology, Inc. (VIR)Equibles does not estimate personal net worth.
Get an email with a short summary when Vir Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.
Get VIR alertsAbout Elliott Sigal
Elliott Sigal is recorded as Board Member at Vir Biotechnology, Inc. (VIR) since January 1, 2020. The newest filing on record that lists Elliott Sigal as Board Member at Vir Biotechnology, Inc. (VIR) is dated April 16, 2026. Earlier roles on record: Board Member at Adaptimmune Therapeutics PLC (ADAPY) until November 1, 2023. Adaptimmune Therapeutics PLC reported in an 8-K filed November 3, 2023 that Elliott Sigal resigned as member of the Board of Directors, effective November 1, 2023. Vir Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vir Biotechnology, Inc. includes Marianne De Backer, MSc, Ph.D., MBA (CEO and Board Member), Aziz Sawaf (CFO), Brent Sabatini (CFO) and 7 others.
“On November 1, 2023, Dr. Elliott Sigal, a member of the Board of Directors of Adaptimmune Therapeutics plc (the "Company" or "Adaptimmune") resigned from the Company's Board of Directors (the "Board") effective on November 1, 2023.”
Affiliation history
-
Current
2020-01-01–present
Last confirmed April 16, 2026
-
Start not stated–2023-11-01
Company network
Leadership on record at Vir Biotechnology, Inc.
- Marianne De Backer, MSc, Ph.D., MBA CEO, Board Member
- Aziz Sawaf CFO
- Brent Sabatini CFO
- Howard Horn CFO
- Jason O'Byrne CFO
- Johanna Friedl-Naderer COO
- Michael Kamarck CTO
- Vanina de Verneuil General Counsel
- Janet Napolitano Board Member
- Robert More Board Member